Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Le Pari De Pascal and The Zen of CLARITAS

<< Previous

Bullboard Posts

Next >>

Comment by Amazighon Aug 28, 2021 7:37pm

161 Views

Post# 33778861

RE:RE:RE:RE:RE:RE:RE:RE:Le Pari De Pascal and The Zen of CLARITAS

Why can't you short it? If you do a sell order of 1,500,000 shares at $0.25 with nacked shorts you will definitely get them sold. Wait then till the SP is $0.025 and buy them back. Easy $337,500 earning I would think. I read with nacked shorts you can easily wait several months before you have to cover. Go for it, I would say!

Scotty wrote: To mock the religious bagholders mainly. I know all of you will hold this back to 2.5c. I can't short this like I hoped, there isn't any volume. Maybe I can buy the announcements and make a quick 10% ish before it bleeds down again.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions